Diagnosing and Treating Anemia
Diagnostic Approach
- The American Society of Hematology guidelines diagnose anemia when hemoglobin levels fall below 135 g/L in adult males and 120 g/L in adult females, requiring a systematic evaluation of potential causes and appropriate treatment based on etiology 1, 2
- A complete blood count (CBC) with red cell indices is used to classify anemia as microcytic, normocytic, or macrocytic 1, 2
- Iron studies, including serum ferritin and transferrin saturation, are used to evaluate iron status 1, 2
- Kidney function tests are used to evaluate for renal disease as a potential cause of anemia 1, 3
Classification of Anemia
- Microcytic anemia (MCV < 80 fL) may be caused by iron deficiency, thalassemia, anemia of chronic disease, or lead poisoning 3
- Normocytic anemia (MCV 80-100 fL) may be caused by anemia of chronic disease, renal failure, or endocrine disorders 3
- Macrocytic anemia (MCV > 100 fL) may be caused by vitamin B12 or folate deficiency, hypothyroidism, or myelodysplasia 3
Treatment Approach
- The American Society of Hematology recommends oral iron supplementation as first-line therapy for iron deficiency anemia 6
- Intravenous iron may be used for patients with intolerance to oral iron, chronic kidney disease with poor response to oral iron, or inflammatory bowel disease 6
- Erythropoiesis-stimulating agents (ESAs) may be considered in severe or symptomatic anemia, particularly in chronic kidney disease 4, 6
Special Considerations
- Regular monitoring of hemoglobin levels is recommended, at least every three months in patients with chronic kidney disease 1, 6
- Standard definitions of anemia may not apply to certain populations, including pregnant or menstruating women, those living at high altitude, smokers, elderly individuals (≥70 years), non-Caucasian races, and those with chronic lung disease or hemoglobinopathy 1, 3